Mahon; Francois-Xavier

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mahon; Francois-Xavier.The latest application filed is for "method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors".

Company Profile

0.1.13

Mahon; Francois-Xavier - Bordeaux FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of Optimizing the Treatment of Philadelphia-positive Leukemia with Abl Tyrosine Kinase Inhibitors App 20170007605 - Gathmann; Insa ; et al.	2017-01-12
Use of Defensin Alpha 1 and/or Defensin Alpha 4, as a Marker for Predicting Treatment Response and/or a Relapse in a Patient Suffering form Chronic Myeloid Leukemia App 20110190220 - Turcq; Beatrice ; et al.	2011-08-04
Organic Compounds App 20110129852 - Barthe; Christophe ; et al.	2011-06-02
Mutated Abl Kinase Domains App 20100021920 - Barthe; Christophe ; et al.	2010-01-28
Mutated Abl Kinase Domains App 20100021921 - Barthe; Christophe ; et al.	2010-01-28
Method Of Optimizing The Treatment Of Philadelphia-positive Leukemia With Abl Tyrosine Kinase Inhibitors App 20090281113 - Gathmann; Insa ; et al.	2009-11-12
Organic Compounds App 20090191606 - Barthe; Christophe ; et al.	2009-07-30
Organic compounds App 20060148058 - Barthe; Christophe ; et al.	2006-07-06
Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents Grant 6,987,103 - Robin , et al. January 17, 2	2006-01-17
Mutated abl kinase domains App 20050202519 - Barthe, Christophe ; et al.	2005-09-15
Use of at least one abl, kit and/or platelet-derived growth factor receptor tyrosine kinases inhibitor for treating hair depigmentation App 20050049268 - Mahon, Francois-Xavier ; et al.	2005-03-03
Treatment of chronic myelogenous leukemia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents App 20040019036 - Robin, Jean-Pierre ; et al.	2004-01-29
Organic compounds App 20030170851 - Barthe, Christophe ; et al.	2003-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.